Australia's healthtech firm ImExHS (ASX:IME) launches Aquila in Thai market

Be the First to Comment Read

Australia's healthtech firm ImExHS (ASX:IME) launches Aquila in Thai market

More on:
ASX IME, IME Thailand business, IME share price
Image source: © Avatavat | Megapixl.com

Highlights

  • Australian medical imaging software provider ImExHS got Thai FDA approval for its PACS technology.
  • The company received the first Aquila in the Cloud order from BJC. 
  • IME has also signed an international software distribution agreement with BJC Healthcare company. 

The leading Australian medical imaging software provider ImExHS Limited’s shares (ASX:IME) closed in green as the company announced to received Thai FDA approval.

As per the release, IME has spread its wings in the Thai market after getting Food and Drug Administration (FDA) approval from Thailand for its PACS technology. Also known as HIRUKO Essential software suite, PACS is an IME's unique Imaging software suite. 

Related read - EnviroSuite’s (ASX:EVS) total ARR nears AU$50 million

The company also revealed that it had signed an international software distribution agreement with BJC Healthcare Company, a part of the Berli Jucker Group, a leading medical equipment provider.

IME has received the first Aquila in the Cloud order from BJC for its Bangkok-based Siriraj Hospital's Mobile Stroke Unit. The company is excited to launch its user-friendly medical imaging platform to the Thailand market as the country’s rapidly ageing population is driving significant demand for healthcare services. 

On the development, co-founder, and CEO of ImExHs Dr German Arango said:

Bottomline 

As Siriraj is one of the oldest and largest Thai hospitals, with over 2,000 beds, this contract is likely to add significant value to IME's business ventures. 

Disclaimer

Speak your Mind

Featured Articles

Ad
kalkine logo

GET A FREE STOCK REPORT

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK